Drug-like properties and the causes of poor solubility and poor permeability.

@article{Lipinski2000DruglikePA,
  title={Drug-like properties and the causes of poor solubility and poor permeability.},
  author={Christopher A. Lipinski},
  journal={Journal of pharmacological and toxicological methods},
  year={2000},
  volume={44 1},
  pages={
          235-49
        }
}
  • C. Lipinski
  • Published 2000
  • Chemistry, Medicine
  • Journal of pharmacological and toxicological methods
There are currently about 10000 drug-like compounds. These are sparsely, rather than uniformly, distributed through chemistry space. True diversity does not exist in experimental combinatorial chemistry screening libraries. Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics… Expand
High-throughput physicochemical and in vitro ADMET screening
During drug discovery, it is important to optimise the affinity for the biomolecular target and also the properties of molecules that influence absorption, distribution, metabolism, excretion, andExpand
Quantitative Structure–Property Relationships Models for Lipophilicity and Aqueous Solubility
The physicochemical properties of a drug molecule, such as lipophilicity and aqueous solubility, have profound effects on the ADMET (absorption, distribution, metabolism, elimination, and toxicity)Expand
Chapter 29 Computational Models for ADME
Publisher Summary Synthesis of potent molecule that has poor exposure in vivo and thus poor efficacy can be caused by many different factors. Most of the factors affecting exposure are commonly knownExpand
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.
TLDR
Aqueous solubility is essential for drug candidates and application of combinatorial chemistry and highthroughput screening (HTS) systems has tended to change the profile of compound libraries in the direction of greater hydrophobicity and higher molecular weight, and this in turn has resulted in a profile of lowersolubility. Expand
THERMODYNAMICS IN DRUG DESIGN. HIGH AFFINITY AND SELECTIVITY
In drug discovery, active compounds identified by screening or other approaches usually bind to their targets with micromolar or weaker affinities. To become effective drugs, the binding affinitiesExpand
Hydrodynamic effects on supersaturated solutions
Along with development of high throughput screening, the number of drug candidates with poor solubility in water and/or poor permeable abilities has increased. This is a problem when oral drugExpand
When poor solubility becomes an issue: from early stage to proof of concept.
TLDR
The conference focused specifically on the impact of compounds with poor solubility on analytical evaluation, prediction of oral absorption, substance selection, material and formulation strategies and development. Expand
Selecting oral bioavailability enhancing formulations during drug discovery and development
  • S. Leucuţa
  • Chemistry, Medicine
  • Expert opinion on drug discovery
  • 2014
TLDR
The genomic methodology, coupled with combinatorial chemistry, high-throughput screening, structure-based design and in silico ADMET would yield parameters as a starting point for the biopharmaceutical properties determination in further preclinical and clinical studies. Expand
Fundamental Methods in Drug Permeability, pKa, LogP and LogDx Determination
Potential drug molecular leads from plants are usually tested for their efficacy in bioactivity assays in preclinical trials. This is followed by testing for the properties of the molecularExpand
Computational Models Supporting Lead Optimization in Drug Discovery
Design of successful drug development candidates requires balancing a number of different characteristics simultaneously including intrinsic activity, biopharmaceutical properties, synthesis,Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 19 REFERENCES
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
TLDR
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described and useful predictions are possible in closely related analog series when coupled with experimental thermodynamicsolubility measurements. Expand
Enhancing the Hit-to-Lead Properties of Lead Optimization Libraries
TLDR
This paper describes a Monte Carlo search procedure that allows the selection of a near-combinatorial subset in which all library members satisfy the design criteria and illustrates how consideration of calculated log P, molecular weight, and polar surface area in the design of a combinatorial library can lead to compounds with improved absorption characteristics. Expand
Physical chemical properties of oral drug candidates in the discovery and exploratory development settings
Abstract The advent of automated in vitro screening of hundreds of thousands of compounds has introduced biases into the drug discovery process that have significant implications for subsequent drugExpand
Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption.
  • D. E. Clark
  • Chemistry, Medicine
  • Journal of pharmaceutical sciences
  • 1999
TLDR
It is shown that consideration of only a single conformer when computing PSA gives an excellent correlation with intestinal absorption data-as good as previously reported methods employing multiple conformers. Expand
Measuring diversity: experimental design of combinatorial libraries for drug discovery.
TLDR
New methods to quantify molecular diversity using descriptors that characterize lipophilicity, shape and branching, chemical functionality, and specific binding features are described and quantify the overall diversity accessible to different families of combinatorial chemistry. Expand
Drug discovery: a historical perspective.
TLDR
The biotech industry is establishing itself as the discovery arm of the pharmaceutical industry, and in bridging the gap between academia and large pharmaceutical companies, the biotech firms have been effective instruments of technology transfer. Expand
Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?
TLDR
A Bayesian neural network is used to distinguish between drugs and nondrugs and it is proposed to use the models to design combinatorial libraries to supplement standard diversity approaches to library design. Expand
On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism.
  • D. Lewis
  • Biology, Medicine
  • Biochemical pharmacology
  • 2000
TLDR
Molecular templates of superimposed substrates are shown to be complementary with the putative active sites of the relevant enzymes, thus enabling a possible prediction of P450 specificity from structure. Expand
A scoring scheme for discriminating between drugs and nondrugs.
TLDR
A scoring scheme for the rapid and automatic classification of molecules into drugs and nondrugs was developed and revealed features in the molecular descriptors that either qualify or disqualify a molecule for being a drug. Expand
Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity.
TLDR
The model, termed "Quantized Surface Complementarity Diversity" (QSCD), allows for individual points in diversity space to be filled by direct modeling of molecular libraries into detailed 3D templates of shape and functionality. Expand
...
1
2
...